To the editor: As the consulting hematologist to a neurosurgery service, I saw two patients with coagulopathy and minor bleeding in whom hetastarch (hydroxyethyl starch) was used to expand plasma volume. These patients had previously had minor surgery without bleeding.
Patient 1: A previously healthy 27-year-old man had surgery to clip a subarachnoid hemorrhage after a posterior communicating aneurysm ruptured. His preoperative coagulation screen yielded normal values for prothrombin time (PT, 12.7 s) and partial thromboplastin time (PTT, 24 s). The patient developed abnormal coagulation variables after surgery while being given 1 to 2 L/d of hetastarch: PT, 15 s;
Learn more about subscription options.
Register Now for a free account.
Hetastarch and Bleeding Complications. Ann Intern Med. 1986;105:627-628. doi: 10.7326/0003-4819-105-4-627_3
Download citation file:
Published: Ann Intern Med. 1986;105(4):627-628.
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only